In the first episode of 2024, Shobita and Jack reflect on the first CRISPR therapy approved by drug regulators around the world, for sickle cell disease. We also talk about the safety issues plaguing Boeing, and the Post Office scandal roiling the UK and why it matters for regulating AI. And, we...
Published 02/02/24